Effects of COVID-19 Lockdown on Heart Failure Patients: A Quasi-Experimental Study

Juan Luis Sánchez-González1, Luis Almenar-Bonet2,3,4, Noemí Moreno-Segura5

  • 1Department of Nursing and Physiotherapy, University of Salamanca, 37007 Salamanca, Spain.

PubMed

Insights

COVID-19 lockdowns reduced physical activity (PA) in heart failure (HF) patients. While sleep quality and quality of life (QoL) were unaffected overall, targeted PA programs are crucial for HF patient well-being during health crises.

Area of Science:

  • Cardiology
  • Public Health
  • Exercise Science

Background:

  • The COVID-19 pandemic and associated lockdowns have raised concerns about reduced physical activity, quality of life, and sleep quality.
  • Limited research exists on the specific impact of these lockdowns on individuals with heart failure (HF).

Purpose of the Study:

  • To investigate the influence of the COVID-19 lockdown on physical activity (PA), quality of life (QoL), and sleep quality in heart failure patients.
  • To compare these effects across different age groups and sexes.

Main Methods:

  • A quasi-experimental, cross-sectional study design was employed, comparing data from during the COVID-19 lockdown (March-June 2020) with post-lockdown (July-October 2020).
  • 107 heart failure patients completed assessments for total PA, walking PA, QoL, and sleep quality using validated questionnaires (IPAQ, Cantril Ladder, Minimal Insomnia Symptom Scale).

Main Results:

  • Heart failure patients exhibited significantly lower total PA and walking PA during the lockdown compared to the post-lockdown period (p<0.001).
  • No significant differences in overall QoL or sleep quality were observed between the two periods.
  • Both younger and older patients, as well as men and women, reported reduced PA during lockdown. Older patients and women specifically reported lower QoL during the lockdown period.

Conclusions:

  • Heart failure patients experienced a decline in physical activity levels during the COVID-19 lockdown.
  • Interventions focusing on improving physical activity programs for heart failure patients during lockdown periods are essential.
  • Enhanced PA programs can potentially improve physical activity levels and quality of life, mitigating risks of decompensation during health crises.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
396